Therapeutic drug monitoring of vancomycin in patients receiving haemodialysis: time for a change.
作者信息
Fitzpatrick F, McGaley T, Rajan L, Crowley R, Turley M, Humphreys H, Smyth E
出版信息
J Clin Pathol. 2006 Jun;59(6):666-7.
Abstract
摘要
相似文献
1
Therapeutic drug monitoring of vancomycin in patients receiving haemodialysis: time for a change.
J Clin Pathol. 2006 Jun;59(6):666-7.
2
Serum levels of vancomycin should be monitored in burn patients.
Burns. 2004 Jun;30(4):386-7. doi: 10.1016/j.burns.2003.11.007.
3
Vancomycin peak serum concentration monitoring.
J Intraven Nurs. 1999 Nov-Dec;22(6):336-42.
4
An update on vancomycin dosing and monitoring practices in hemodialysis patients.
CANNT J. 2013 Oct-Dec;23(4):25-7; quiz 28-9.
5
[Glycopeptides (vancomycin, teicoplanin)].
Nihon Rinsho. 2004 Dec;62 Suppl 12:423-6.
6
Pitfalls in TDM of antibiotic drugs: analytical and modelling issues.
Ther Drug Monit. 2006 Oct;28(5):686-9. doi: 10.1097/01.ftd.0000243966.97964.11.
7
[Glycopeptides (vancomycin, teicoplanin)].
Nihon Rinsho. 1999 Sep;57 Suppl:401-3.
8
Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring.
J Infect Chemother. 2013 Jun;19(3):365-80. doi: 10.1007/s10156-013-0599-4. Epub 2013 May 15.
9
[Behaviour of vancomycin with the new techniques in haemodialysis].
Nefrologia. 2005;25(5):527-34.
10
Vancomycin dosing and monitoring.
Med Lett Drugs Ther. 2009 Apr 6;51(1309):25.
引用本文的文献
1
Independent specimens are important.
J Clin Pathol. 2007 Jul;60(7):848.
本文引用的文献
1
Evaluation of commercial assays for vancomycin and aminoglycosides in serum: a comparison of accuracy and precision based on external quality assessment.
J Antimicrob Chemother. 2003 Jul;52(1):78-82. doi: 10.1093/jac/dkg296. Epub 2003 Jun 12.
2
Vancomycin therapeutic drug monitoring: is there a consensus view? The results of a UK National External Quality Assessment Scheme (UK NEQAS) for Antibiotic Assays questionnaire.
J Antimicrob Chemother. 2002 Nov;50(5):713-8. doi: 10.1093/jac/dkf212.
3
Implications of vancomycin degradation products on therapeutic drug monitoring in patients with end-stage renal disease.
Pharmacotherapy. 1999 Jun;19(6):702-7. doi: 10.1592/phco.19.9.702.31548.
4
New modified fluorescence polarization immunoassay does not falsely elevate vancomycin concentrations in patients with end-stage renal disease.
Ther Drug Monit. 1998 Apr;20(2):231-5. doi: 10.1097/00007691-199804000-00016.
5
Falsely elevated serum vancomycin concentrations in hemodialysis patients.
Am J Kidney Dis. 1996 Jan;27(1):67-74. doi: 10.1016/s0272-6386(96)90032-3.
Zotero 插件